IBI-363
IBI-363 is a PD-1/IL-2 bispecific antibody and can be used for the research of cancer, such as non-small cell lung cancer[1].
Product Specifications
UNSPSC
12352005
Target
Interleukin Related; PD-1/PD-L1
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[IBI-363]
References & Citations
[1]Zhou J, et al. MA11. 04 first-in-class PD-1/IL-2 bispecific antibody IBI363 in patients with advanced non-small cell lung cancer in a phase I study[J]. Journal of Thoracic Oncology, 2024, 19 (10) : S97.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
IL-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS642117-01 0.2 mL
IP6K1, NT (IP6K1, IHPK1, KIAA0263, Inositol hexakisphosphate kinase 1, Inositol hexaphosphate kinase 1)
Ask
View Details 
MBS642117-02 5x 0.2 mL
IP6K1, NT (IP6K1, IHPK1, KIAA0263, Inositol hexakisphosphate kinase 1, Inositol hexaphosphate kinase 1)
Ask
View Details